FDA Inspection 751866 — Anika Therapeutics, Inc.

Anika Therapeutics, Inc. — FEI 3007093114

The FDA completed an inspection of Anika Therapeutics, Inc. on October 31, 2011 in Bedford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 31, 2011
Fiscal Year
2012
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Bedford, MA (United States)